Galapagos | Zysk Brutto



Pre Tax Profit Zmiana Data
argenx SE USD 88.02M 103.02M 2024-09
AstraZeneca USD 1.67B 162M 2024-12
Biogen USD 572.2M 118.5M 2024-12
Genmab DKK 3.6B 1.88B 2024-12
Gilead Sciences USD 2.96B 112M 2024-12
GlaxoSmithKline GBP 563M 2.08B 2024-12
GRIFOLS EUR 66.98M 38.41M 2024-06
Hikma Pharmaceutical USD 144M 144M 2024-06
Incyte USD 406.83M 147.12M 2024-12
Merck EUR 1.23B 449.38M 2024-09
Neurocrine Biosciences USD 162.6M 27.7M 2024-12
Novartis USD 4.66B 269M 2024-12
Roche Holding CHF 1.78B 2.33B 2024-12
Sanofi EUR 2.18B 1.33B 2024-12
UCB EUR 123M 464.07M 2024-06
Vertex Pharmaceuticals USD 1.32B 109.7M 2024-12



Galapagos Zysk Brutto - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Mar 2025.